Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients
Launched by THIRD AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Jun 12, 2014
Trial Information
Current as of June 27, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age from over 20 to under 60 years;
- • Primary rectal adenocarcinoma confirmed pathologically by endoscopic biopsy;
- • Mid-low rectal cancer (distance from anal edge≤12cm);
- • cT1-3, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition;
- • Expected curative resection through both L-PANP-TME and O-PANP-TME;
- • Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale;
- • ASA (American Society of Anesthesiology) score class I, II, or III;
- • Written informed consent;
- • Urinary and sexual function normal preoperatively
- Exclusion Criteria:
- • Women during pregnancy or breast-feeding;
- • Severe mental disorder;
- • History of previous pelvic surgery;
- • Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging;
- • History of other malignant disease within past five years;
- • History of unstable angina or myocardial infarction within past six months;
- • History of cerebrovascular accident within past six months;
- • History of continuous systematic administration of corticosteroids within one month;
- • Contraindication of heart, brain, lung, etc dysfunction;
- • Requirement of simultaneous surgery for other disease;
- • Emergency surgery due to complication (bleeding, obstruction or perforation) caused by rectal cancer;
- • Rectal cancer invades surrounding tissues;
- • Existence of genuine incontinence or severe stress incontinence preoperatively
About Third Affiliated Hospital, Sun Yat Sen University
The Third Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its comprehensive resources and multidisciplinary expertise to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on collaboration and patient-centered care, the Third Affiliated Hospital is dedicated to fostering advancements in medical science and ensuring the highest standards of ethical practice in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials